(Q50645808)

17 March 2018

editorial

0 references

title

Neurodevelopmental origin of cognitive impairment in schizophrenia. (English)

1 reference

17 March 2018

main subject

schizophrenia

0 references

cognitive dysfunction

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065902%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

E Bora

series ordinal

1

1 reference

17 March 2018

language of work or name

English

0 references

publication date

30 May 2014

1 reference

17 March 2018

published in

Psychological Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065902%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065902%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065902%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

1-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065902%20AND%20SRC:MED&resulttype=core&format=json

Executive functions in children aged 6 to 13: a dimensional and developmental study

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Cognitive reserve in ageing and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

White matter hyperintensities and cognition: testing the reserve hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

What is cognitive reserve? Theory and research application of the reserve concept

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS0033291714001263

21 January 2018

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Aberrant frontal lobe maturation in adolescents with fragile X syndrome is related to delayed cognitive maturation

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Widespread and sustained cognitive deficits in alcoholism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Is There Evidence for Late Cognitive Decline in Chronic Schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Microstructural white matter changes in metabolic syndrome: a diffusion tensor imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Risk of adult schizophrenia and its relationship to childhood IQ in the 1958 British birth cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Is schizophrenia a neurodevelopmental disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Is schizophrenia a neurodegenerative disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Cognitive reserve in neuropsychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Development of executive functions through late childhood and adolescence in an Australian sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Superior intellectual ability in schizophrenia: neuropsychological characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Relationship between metabolic syndrome and cognition in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

IQ decline during childhood and adult psychotic symptoms in a community sample: a 19-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Apathy, cognitive deficits and functional impairment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

A meta-analysis of structural brain abnormalities in PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Consistent impaired verbal memory in PTSD: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Microstructural white matter abnormalities in type 2 diabetes mellitus: a diffusion tensor imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

IQ change over time in schizophrenia and healthy individuals: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Negative symptoms and cognitive deficits: what is the nature of their relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Cognitive and functional impairments in elderly patients with schizophrenia: a review of the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Longitudinal changes in intellectual development in children with Fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

The relationship between obesity and neurocognitive function in Chinese patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

The effects of hypertension and body mass index on cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Cognitive and functional changes with aging in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

An active and socially integrated lifestyle in late life might protect against dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Negative symptoms in schizophrenia: avolition and Occam's razor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Posttraumatic stress disorder, cognitive function and quality of life in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

The effects of guided discontinuation of antipsychotics on neurocognition in first onset psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Alcohol use and cerebral white matter compromise in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

‘Pfropfschizophrenie’ revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Childhood cognitive ability and risk of late-onset Alzheimer and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Neuroleptics and the Natural Course of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Early expression of negative/disorganized symptoms predicting psychotic experiences and subsequent clinical psychosis: a 10-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Characterizing trajectories of cognitive functioning in older adults with schizophrenia: does method matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Diabetes is associated with lower global cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Trajectories of social withdrawal and cognitive decline in the schizophrenia prodrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

High prevalence of dementia among people with learning disabilities not attributable to Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Neuropsychology of the deficit syndrome: new data and meta-analysis of findings to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Longitudinal studies of cognition in schizophrenia: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Incidence of dementia in older adults with intellectual disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Nature and course of cognitive function in late-life schizophrenia: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Developmental lag and course of cognitive deficits from the premorbid to postonset period in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Neurocognitive deterioration in elderly chronic schizophrenia patients with and without PTSD.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Rethinking schizophrenia in the context of normal neurodevelopment

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Cognitive deficits in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Pathways to functional outcomes in schizophrenia: the role of premorbid functioning, negative symptoms and intelligence

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291714001263

7 January 2021